news roundup

Take Our Survey!

Applied Clinical Trials and SCORR want to know more about your innovations in clinical trial design. Please take this brief, 25-question survey to give us insight on your design process, resources needed to make changes, benchmarks used to measure performance of changes, and the impact new clinical trial designs have had on your work.

Synteract Centers of Therapeutic Development

Synteract, a full-service, Phase I-IV CRO announced the creation of therapeutic centers of development that include oncology, especially leading edge immunotherapy studies, neuro-degenerative disorders, pediatrics, and rare and orphan disease.

OmniComm's TrialMaster EDC Selected by Topstone Research

Topstone Research, a full-service CRO, has signed a new agreement with OmniComm Systems, Inc., a provider of clinical data management technology, to use OmniComm's TrialMaster EDC technology in order to develop clinical studies at multiple Topstone research sites.

New Release of Cenduit's IRT Platform and Quantum Interactive

With the latest release of the Cenduit IRT platform and Quantum Interactive, Cenduit LLC continues to drive innovation and quality as part of the Interactive Response Technology (IRT) marketplace. This release will enable technology transfer along with increased reports customization for clinical trials.

Articles

Why Cash (and Checks) Aren't King in Phase I Trials

The adoption of automated payment methods for phase I trials will allow for more effective clinical trials.

Risk Based Budgeting

Adoption of the concept of Risk-Based Budgeting could help maintain the trial budget or even save the whole clinical trial.

Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com